A unified visualization and simulation package
Unable to incorporate your own algorithms into discovery applications when modeling protein structures? Need a unified package to facilitate post-translational modifications? The computational drug discovery solution from IBM and CCG is an integrated visualization and simulation solution that allows scientists to easily customize their own applications.

The advantage

Designed for life sciences IBM delivers reliable infrastructure solutions developed and enhanced for life sciences. CCG has a highly qualified team of researchers committed to applying technology to life sciences challenges.

The computational drug discovery solution from IBM and CCG:
Features a flexible tool that incorporates new mathematical and scientific ideas to streamline drug discovery.
Provides a highly intuitive, diverse application suite for:
Bioinformatics
Cheminformatics
High-throughput discovery
Structure-based design
Protein and homology modeling
Molecular modeling and simulations
Methodology development and deployment
Has been developed using Scientific Vector Language (SVL) to enable uncomplicated customization of life sciences applications by scientists.


The benefits

Enhance scientist productivity and decision making
The computational drug discovery solution from IBM and CCG enables scientists to take more control of the discovery process
Offers an integrated package of visualization and simulation technologies-so you don't spend inordinate amounts of time manipulating data between applications
Enables you to customize applications and incorporate your own algorithms in minimal development time-with little or no tech support
Facilitates post-translational modifications through rapid computational design
Allows scientists to share in-house data across all platforms and operating systems effortlessly
Features easy-to-use interfaces
Delivers a unified suite of drug discovery tools that operates on the departmental server, the graphical workstation or a laptop
Enables relevant structure-based data to be integrated from multiple sources, with the resulting output available for use in downstream applications
Offers an integrated software suite that combines applications for high-throughput discovery and computer-aided molecular design-while providing tools for cheminformatics and bioinformatics
Offers a solution that's optimized on IBM technologies—allowing scientists to leverage powerful computing speed and portability when using visualization applications


The approach

A rich set of protein modeling tools The computational drug discovery solution from IBM and CCG can help enhance discovery efforts. Enables scientists to rewrite to and from IBM DB2® data management systems, so you can incorporate structure-based data from multiple sources into MOE for molecular modeling—accelerating your ability to perform post-translational modifications "in silico" Helps scientists leverage powerful visualization tools, bringing new dimensions to computer-aided drug design, and accelerating protein modeling and identification of molecular targets Enables scientists to gain more detailed information on protein reactions by leveraging powerful eServer and Linux cluster technologies to perform post-translational modifications Allows scientists to deploy findings and results to other users via the MOE graphical user interface or a Web browser—enhancing productivity and decision making throughout the lab environment


The financial advantage

More economical drug discovery
The computational drug discovery solution from IBM and CCG can enhance business value by:
Offering an affordable solution for drug design.Providing internationally-supported usage licenses—for heightened ROI in geographically dispersed organizations.Facilitating the ability of scientists to perform post-translational modifications, enhancing the efficiency and effectiveness of discovery research and making your company more competitive.